The herd tends to overreact to extremes, overstimulating a stock on positive momentum and equally over-panicking on negative headlines. Nike has been around for 60 years; it went public in the 80s and has dominated Athletic wear and sports fashion …
Source: [Dataroma](https://www.dataroma.com/m/g/portfolio_b.php?q=q&o=c) MSFT - Microsoft Corp. META - Meta Platforms Inc. V - Visa Inc. AMZN - Amazon.com Inc. BRK.B - Berkshire Hathaway CL B SPGI - S&P Global Inc. GOOG - Alphabet Inc. CL C DIS - Walt Disney …
This sub strongly benefits from swarm intelligence. Stock analysis from some and critical opinions from others. This leads to subs favorites like MSFT, META, ADBE, PAYP, FIVS, INTU, NOW, ... (list goes on). Would be interesting to know if this …
It obviously looks cheap at the moment but given how much competition there is in the sector, both within China and outside of it, I don't think there's much of a moat around the business. Temu has a terrible reputation …
I started looking at OCL when the indicators from my deep dive scoring system and side by side comparison all went green. You can see the comparison in the link below on the website. This is by no means a …
Berkshire Hathaway just made Alphabet its third-largest position at 11.7%. That's a very large position by Berkshire's standards. Given search's vulnerability to disruption, I was surprised Warren Buffett would advocate such a position, given that a durable moat is his …
A few people have asked for more data to support the numbers I've been publishing in my CSL and RMD posts. Others have suggested the work is AI generated. I can confirm that everything is 100% HI generated, powered by …
This is separate from my 20 company dividend stock challenge. Just to show I'm not a one-trick pony. About a month ago, I started buying 11 non-dividend-focused stocks that I believed offered attractive risk/reward opportunities. Unlike my dividend portfolio experiment, …
I’ve been looking at it and I’m curious how people view it In Q2 2026 Teva did about $4.1B in revenue and generated $622M in free cash flow. Its newer drugs also seem to be becoming a much better selling …
I like to look at Valley Forge 13F, cause Dev Kautesaria keeps a tight concentrated position, so its easy to follow and understand. The holdings are also straightforward, and mostly predictable, financial and credit scoring oligopolies, and have moats. I …